Loading organizations...
Fundación para el Progreso de la Medicina (FPM) operates a high-complexity clinical analysis laboratory, providing advanced diagnostic services. It integrates sophisticated techniques for sample processing, employing state-of-the-art technology. Capabilities include radioimmunoassay, flow cytometry, immunohistochemistry, and molecular biology (PCR) for precise analysis. FPM delivers comprehensive clinical diagnostics for patient care.
Founded April 19, 1962, by Hospital Privado medical professionals, FPM initially focused on health research. Dr. Eduardo De Arteaga, a distinguished medical pioneer, shaped its early growth. In 1978, the Clinical Analysis Laboratory was established, becoming its sole focus by 2007. Dr. Samuel Taleisnik, an esteemed researcher, then guided diagnostic innovation.
FPM serves patients and medical practitioners needing specialized clinical diagnostics, prioritizing personalized attention. Its mission: generate knowledge via research, applying innovative diagnostic techniques efficiently and sustainably. FPM aims for biomedicine excellence, particularly oncology, aspiring to be the regional reference for high-complexity analysis, known for reliability, professionalism, and advanced technology.
Fundación Para el Progreso de la Medicina has 1 tracked investment across 1 company. The latest tracked deal is $3.3M Seed in OncoPrecision in October 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 31, 2022 | OncoPrecision | $3.3M Seed | — | Kulika Weizman, GridX, NEW York Ventures, SOSV |